{"name":"Topokine Therapeutics, Inc.","slug":"topokine-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"TAT4 Gel concentration B","genericName":"TAT4 Gel concentration B","slug":"tat4-gel-concentration-b","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"TAT4 Gel concentration B","genericName":"TAT4 Gel concentration B","slug":"tat4-gel-concentration-b","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPMjctYmpoLTdoZG5Zc3BoV0w3YVZfS2pwN0lOOWNnR0ZZTzV5ekJRaGdKYVdpZXhNQ3RZb05QVG9rU3NNRXl0WEY4YWF6TU5mQmctQ3llazZOTElrN0RGZDZhT1lpVWtLRUttVmxPM1FJR3ViOG52ajVSZTBwZ3RFcV9WUUFXOEJ1QXliTnllbGxHOEE?oc=5","date":"2024-06-21","type":"pipeline","source":"SEC.gov","summary":"abbv-20221231xex21.htm - SEC.gov","headline":"abbv-20221231xex21.htm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPSEp4ZFFMQUhqT1B6T1pxSUN5T0JvVjJHMll2TGJpczd4RTVVYU9Xd2ZxTlJPVkZKU1F4ak5OdlR5RzIybDJ1R21xd3J3bXd5OENXdXNaVU1POV9MMUc2NTJvTWxIeVlhRmxlQ181UzNzNmNlYTNRMUtJZkV6emRkMVhQTm5EMHRMSmVKT2w2bW51WkNCRk9KRkVlYTd1RERp?oc=5","date":"2021-09-28","type":"pipeline","source":"The Business Journals","summary":"Gaithersburg biopharma prepares to double footprint, headcount - The Business Journals","headline":"Gaithersburg biopharma prepares to double footprint, headcount","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPQXp2Z19UUmZNelJmazg2b05vcHNpc3FfUFk4V2Z5a2Fka09ZcUZ1elpKamdsck5Jb09xSGJFNWFnVDhfM2tJdXF6a1ZWaS1NYlBqZGZiVHp6Wm44dzdrVklHU2owV2VRUEtsMFFHekZ4QnBHNDV6Q3ptWGs4MFVFWXNhT3c5eF90akZldGY4YTh5V1VBTml3N3FuWQ?oc=5","date":"2016-04-25","type":"deal","source":"Cosmetics Business","summary":"Allergan acquires Topokine and undereye bag product rights - Cosmetics Business","headline":"Allergan acquires Topokine and undereye bag product rights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPVnMyVWRuczhnckcwSUpwX08zbjhlZDhLc21nTXNSQUgzWE1YZXJwTVkwVmR0Rl8xZnRKX1J5NjQ5eXFJTWdKLWZ2MHBNem5HRnlLN0FJTWV2UmRDa3VxdFF6S1ZxYzh4TFlfb044bjJ0Nmp2MWlocU1maEdJaEJNSG5ydGlvb0pfUGkyQnZjWnRNUUhlS3VPQ0FJbjFWeWdqSjVtbHhfTlhjYnd0TVNXdFAxX0I4aFo5SmJWOGZrVGtHSW9zSGRZaDVCeVk1bGVDRmpsb0U5ZndBU19aM3pOVWhVSVBCc09wRTVkUzJrdDk2aXVXRDFRaTluZWU1YUFoYk5ncnZoaG0?oc=5","date":"2016-04-21","type":"deal","source":"PR Newswire","summary":"Allergan Acquires Topical Dermatology Company Topokine Therapeutics Adding Non-Invasive Fat Reduction Development Program - PR Newswire","headline":"Allergan Acquires Topical Dermatology Company Topokine Therapeutics Adding Non-Invasive Fat Reduction Development Progra","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}